Clinical Trials Directory

Trials / Recruiting

RecruitingNCT00131014

Establishing a Tumor Bank in Families With Multiple Lymphoproliferative Malignancies

Establishing a Tumor Bank and Initial Analysis of Germline and Tumor-Related Genetic Alterations in Families With Multiple Lymphoproliferative Malignancies

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,500 (estimated)
Sponsor
Dana-Farber Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to investigate possible genetic factors that contribute to the development of lymphomas. The databank will be used to determine whether familial lymphomas have unique genetic characteristics different from sporadic lymphomas and to attempt to identify a gene that confers an increased risk of lymphoma.

Detailed description

* Patients who participate will be asked to complete detailed family and medical history questionnaires initially, with a follow-up questionnaire every year. * Patients will be asked to supply a blood sample and possibly a mouthwash sample, both of which can be done by mail. * Patients will be asked to consent to the release of their lymphoma tissue block for the purposes of the study. * Patients will be given letters of invitation for their affected relatives to invite them to participate.

Conditions

Timeline

Start date
2004-08-09
Primary completion
2033-01-01
Completion
2033-01-01
First posted
2005-08-17
Last updated
2025-07-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00131014. Inclusion in this directory is not an endorsement.